SHORT MINI-FUTURE - AMGEN | Delayed Deutsche Boerse AG 04:34:41 2024-07-16 am EDT | ||
| 3.05 EUR | -3.48% |
|
| Current month | -31.90% | ||
| 1 month | -48.28% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-07-16 | 3.05 | -3.48% |
| 24-07-15 | 3.16 | +15.33% |
| 24-07-12 | 2.74 | -16.97% |
| 24-07-11 | 3.3 | -14.06% |
| 24-07-10 | 3.84 | -15.97% |
Delayed Quote Deutsche Boerse AG
Last update July 16, 2024 at 04:34 am EDT
More quotesStatic data
| Product type | Warrant Knock-Out con Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | 
Vontobel
|
| WKN | VU1UME |
| ISIN | DE000VU1UME1 |
| Date issued | 2023-01-06 |
| Strike | 362.8 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 9.95 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 13.98 € |
|---|---|
| Lowest since issue | 2.58 € |
| Spread | 0.13 € |
| Spread % | 3.98% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
330.2
USD
Average target price
317.4
USD
Spread / Average Target
-3.86%
- Stock Market
- Certificates
- Certificat
